303 results on '"Kuenzig, M Ellen"'
Search Results
2. The Epidemiology of Pediatric Inflammatory Bowel Disease
3. Review and content analysis of mobile apps for inflammatory bowel disease management using the mobile application rating scale (MARS): Systematic search in app stores
4. Epidemiology of Pediatric Inflammatory Bowel Disease
5. Incidence, Management, and Outcomes of Very Early Onset Inflammatory Bowel Diseases and Infantile-Onset Disease: An Epi-IIRN Study
6. Earlier Anti-TNF Initiation Leads to Long-term Lower Health Care Utilization in Crohn’s Disease but Not in Ulcerative Colitis
7. Meta-analysis of multi-jurisdictional health administrative data from distributed networks approximated individual-level multivariable regression
8. Real world evidence of the association between medication and life expectancy in elderly inflammatory bowel disease: a population-based cohort study
9. Forecasting the Incidence and Prevalence of Inflammatory Bowel Disease: A Canadian Nationwide Analysis.
10. Health Services Utilization and Specialist Care in Pediatric Inflammatory Bowel Disease: A Multiprovince Population-Based Cohort Study
11. Variation in the Care of Children with Inflammatory Bowel Disease Within and Across Canadian Provinces: A Multi-Province Population-Based Cohort Study
12. Hospitalization with Clostridioides difficile in pediatric inflammatory bowel disease: a population-based study
13. Increased Incidence of Inflammatory Bowel Disease After Hirschsprung Disease: A Population-based Cohort Study
14. Bivalent mRNA SARS-CoV-2 vaccination in patients with inflammatory bowel disease
15. Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data
16. Life expectancy and health-adjusted life expectancy in people with inflammatory bowel disease
17. Venous Thromboembolism After COVID-19 Infection Among People With and Without Immune-Mediated Inflammatory Diseases
18. The 2023 Impact of Inflammatory Bowel Disease in Canada: Treatment Landscape
19. The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD
20. The 2023 Impact of Inflammatory Bowel Disease in Canada: The Influence of Sex and Gender on Canadians Living With Inflammatory Bowel Disease
21. The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—Children and Adolescents with IBD
22. The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—IBD in Seniors
23. The 2023 Impact of Inflammatory Bowel Disease in Canada: Access to and Models of Care
24. The 2023 Impact of Inflammatory Bowel Disease in Canada: Cancer and IBD
25. The 2023 Impact of Inflammatory Bowel Disease in Canada: Indirect (Individual and Societal) and Direct Out-of-Pocket Costs
26. The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD
27. The 2023 Impact of Inflammatory Bowel Disease in Canada: Direct Health System and Medication Costs
28. The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease
29. Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study
30. The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive Summary
31. Asthma Is Associated With Subsequent Development of Inflammatory Bowel Disease: A Population-based Case–Control Study
32. Direct Health Care Costs, Health Services Utilization, and Outcomes of Biliary Atresia: A Population-based Cohort Study
33. Disease-Associated Costs in Children With Inflammatory Bowel Disease: A Systematic Review
34. Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort Study.
35. Co-occurrence of Asthma and the Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis
36. Fecal Incontinence in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
37. Editorial: COVID ‐19 vaccines are safe and effective in patients with inflammatory bowel disease—but many unanswered questions remain
38. The Role of the Urban Exposome in the Increasing Global Rates of Pediatric Inflammatory Bowel Disease
39. Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohnʼs Disease: A Bayesian Network Meta-analysis
40. Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada
41. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review
42. Additional file 1 of Real world evidence of the association between medication and life expectancy in elderly inflammatory bowel disease: a population-based cohort study
43. Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease
44. Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life
45. Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines—Biology, Current Evidence and Recommendations
46. Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Epidemiology—The Trends of Disease Over Time
47. Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications
48. Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD
49. Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy
50. Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease Care
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.